The total return over the past 12 months is +37.43% vs. +19.98% for the S&P 500. So far it's up +24.54% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +33.93% | +25.28% | +15.97% | +6.98% | +14.65% | +11.93% |
| Total Return CAGR | +37.43% | +29.44% | +20.26% | +10.84% | +17.56% | +14.06% |
| Revenue CAGR | +5.52% | +3.61% | +2.72% | (0.61%) | +9.32% | +13.36% |
| Net Income CAGR | (151.34%) | +22.83% | +133.38% | (6.13%) | +7.44% | +12.45% |
| EPS CAGR | (151.38%) | +23.17% | +133.83% | (5.75%) | +9.72% | +14.58% |
| Free Cash Flow CAGR | +40.88% | +13.92% | +9.27% | (2.64%) | +10.02% | +16.44% |
| Operating Cash Flow CAGR | +37.32% | +12.52% | +8.31% | (2.85%) | +10.04% | +16.08% |
| Dividends CAGR | +2.60% | +2.67% | +3.04% | +9.37% | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Gilead Sciences, Inc. (GILD)
| Year | Start price | End price | GILD Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $122.74 | $151.00 | +24.54% | +13.55% | +10.99% |
| 2025 | $92.37 | $122.74 | +36.62% | +17.72% | +18.90% |
| 2024 | $81.01 | $92.37 | +18.64% | +24.89% | (6.25%) |
| 2023 | $85.85 | $81.01 | (2.01%) | +26.19% | (28.20%) |
| 2022 | $72.61 | $85.85 | +23.60% | (18.17%) | +41.77% |
| 2021 | $58.26 | $72.61 | +29.96% | +28.74% | +1.22% |
| 2020 | $64.98 | $58.26 | (6.62%) | +18.37% | (24.99%) |
| 2019 | $62.55 | $64.98 | +7.88% | +31.22% | (23.34%) |
| 2018 | $71.64 | $62.55 | (9.92%) | (4.56%) | (5.36%) |
| 2017 | $71.61 | $71.64 | +2.97% | +21.70% | (18.73%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
